Skip to main content
KBG Corp. logo

KBG Corp. — Investor Relations & Filings

Ticker · 318000 ISIN · KR7318000007 KO Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2020-03-17 Transaction in Own Shar…
Country KR South Korea
Listing KO 318000

About KBG Corp.

http://www.kbgtech.co.kr/en/index.php

KBG Corp. is a fine chemical company specializing in the development, manufacturing, and distribution of silicone-based materials. The company's product portfolio encompasses a wide range of inorganic and organic silicon chemicals, including silane monomers, silane coupling agents, silane crosslinking agents, silicone resins, and reactive silicone fluids. KBG Corp. also produces catalysts for silicone curing and advanced silicone materials specifically designed for the electronics sector and other fusion material applications. The company serves a global customer base.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This type of filing, which details a company's decision to buy back its own shares through a trust, falls under the category of 'Transaction in Own Shares' (POS).
2020-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion, key financial data, and auditor information. While it contains financial data, it is a short announcement (under 5,000 characters) notifying the market that the audit report has been submitted, rather than the full audit report document itself. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA). FY 2019
2020-03-13 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Korea Biogen Co., Ltd. It contains the agenda for the 19th Annual General Meeting, including financial statement approval, director appointments, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, cash flow, etc.) and business reports as part of the meeting materials provided to shareholders. This aligns with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2020-03-09 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Audit Report / Information Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a correction (amendment) to a previously filed report on 'Changes in Sales or Profit/Loss Structure (30% or more)'. It provides updated financial figures (operating profit, net income, assets, liabilities) due to audit adjustments. Since this is a specific regulatory disclosure regarding financial performance updates and corrections, it falls under the 'Regulatory Filings' category as it does not constitute a full annual report or a standard earnings release, but rather a formal regulatory notification of a financial correction. FY 2019
2020-03-05 Korean
주주총회소집결의
AGM Information Classification · 96% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company '한국바이오젠'. It outlines the date, location, and agenda items (such as financial statement approval, dividend declaration, and director appointments). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2020-02-24 Korean
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Regulatory Filings Classification · 95% confidence The document is a formal response to a Korea Exchange (KRX) inquiry regarding significant market fluctuations (unusual stock price/volume activity). It explicitly states that there is no undisclosed material information to report. This type of regulatory disclosure, which does not fit into specific categories like financial reports or M&A, is classified as a general regulatory filing.
2020-02-18 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.